Seoul National University College of Engineering announced that a joint research team led by Professor Namkyoo Park and ...
ThalassaX Therapeutics United States Ltd today announced that the first patient has been successfully dosed in the U.S. Phase I clinical trial of CS231295, a next-generation brain-penetrant Aurora B ...
Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinical-stage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today ...
Cutaneous lupus erythematosus is a chronic autoimmune disease with few treatment options and no approved targeted therapies.
Detailed price information for Beyondspring Inc (BYSI-Q) from The Globe and Mail including charting and trades.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results